5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours

Clinical trial NCT06630260 · RECRUITING

Trial details

NCT number: NCT06630260
Sponsor: Institute of Cancer Research, United Kingdom
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme (GBM)Glioblastoma Multiform (Grade IV Astrocytoma)Diffuse Hemispheric Glioma, H3 G34-Mutant Malignant Primary Gliomas

Start date: 2024-11-15
Primary completion: 2029-09-30
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.